Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole
Public ClinicalTrials.gov record NCT01429441. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Sham-controlled, Double-masked, Multicenter Study Evaluating Ocriplasmin Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole
Study identification
- NCT ID
- NCT01429441
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- ThromboGenics
- Industry
- Enrollment
- 220 participants
Conditions and interventions
Interventions
- Ocriplasmin Drug
- Sham injection Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2011
- Primary completion
- Sep 30, 2014
- Completion
- Sep 30, 2014
- Last update posted
- Mar 13, 2016
2011 – 2014
United States locations
- U.S. sites
- 25
- U.S. states
- 12
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retinal Consultants of Arizona | Phoenix | Arizona | 85014 | — |
| Retina-Vitreous Associates Medical Group | Beverly Hills | California | 90211 | — |
| Retina Consultants Medical Group | Sacramento | California | 95819 | — |
| West Coast Retina Group, Inc | San Francisco | California | 94107 | — |
| Bay Area Retina Associates | Walnut Creek | California | 94598 | — |
| MedEye Associates | Miami | Florida | 33143 | — |
| Center for Retina and Macular Disease | Winter Haven | Florida | 33880 | — |
| Associated Retinal Consultants | Royal Oak | Michigan | 48073 | — |
| Sabates Eye Center Research | Kansas City | Missouri | 64108 | — |
| Eyesite Opthalmic Services, PA | Portsmouth | New Hampshire | 03801 | — |
| Retina-Vitreous Center, PA | New Brunswick | New Jersey | 08901 | — |
| Retina Association of NJ | Teaneck | New Jersey | 07666 | — |
| Retina Vitrous Surgeons of CNY | Syracuse | New York | 13224 | — |
| Southeast Clinical Research, PA | Charlotte | North Carolina | 28210 | — |
| Cincinnati Eye Institute | Cincinnati | Ohio | 45242 | — |
| Retina Associates of Cleveland | Cleveland | Ohio | 44130 | — |
| Mid Atlantic Retina | Huntingdon Valley | Pennsylvania | 19006 | — |
| Texas Retina Associates | Arlington | Texas | 76012 | — |
| Retina Research Center | Austin | Texas | 78705 | — |
| Texas Retina Associates | Dallas | Texas | 75231 | — |
| Retina Consultants, PA | Fort Worth | Texas | 76104 | — |
| Vitroretinal Consultants | Houston | Texas | 77030 | — |
| Valley Retina Institute, P.A. | McAllen | Texas | 78503 | — |
| Retina Consultants of San Antonio | San Antonio | Texas | 78240 | — |
| Eye Care Associate | Tyler | Texas | 75701 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01429441, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 13, 2016 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01429441 live on ClinicalTrials.gov.